Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma
Frederick L. Locke(Moffitt Cancer Center), Sattva S. Neelapu(The University of Texas MD Anderson Cancer Center), Nancy L. Bartlett(Washington University in St. Louis), Tanya Siddiqi(City Of Hope National Medical Center), Julio C. Chávez(Moffitt Cancer Center), Chitra Hosing(The University of Texas MD Anderson Cancer Center), Armin Ghobadi(Washington University in St. Louis), Lihua E. Budde(City Of Hope National Medical Center), Adrian Bot(Kite (United States)), John M. Rossi(Kite (United States)), Yizhou Jiang(Kite (United States)), Allen Xue(Kite (United States)), Meg Elias(Kite (United States)), Jeff Aycock(Kite (United States)), Jeff Wiezorek(Kite (United States)), William Y. Go(Kite (United States))
Cited by 616Open Access